Health

mRNA vaccine manufacturers loath to share know-how

R. Prasad
The FDA authorized booster doses for Americans who are 65 and older, younger adults with underlying health conditions and those in jobs that put them at high risk for COVID-19.
International

U.S. FDA backs Pfizer COVID-19 boosters for senior citizens, high-risk

AP

Other Articles